Caprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Prior Intimation of Board ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Caprolactam Chemicals Ltd has informed BSE that its Board of Directors will meet on May 30, 2025, to consider and approve the Audited Financial Results along with the Auditor's Report for the quarter and financial year ended March 31, 2025. The filing is made under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements. The trading window for dealing in the company's securities has been closed since April 1, 2025, and will remain closed until 48 hours after the results are publicly announced, in line with insider trading norms. No financial figures or business details have been disclosed in this intimation.
This is a routine regulatory filing and does not by itself affect the stock price. Investors should watch for the actual audited results on or after May 30, 2025, to assess the company's FY25 performance.